Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Hindu
The Hindu
National
Bindu Shajan Perappadan

Corbevax, Covaxin get drug regulator nod for use in children between 5 and 12

Amidst an uptick of fresh COVID-19 cases in the country, the Drugs Controller General of India (DCGI) on Tuesday approved the emergency use authorisation for two anti-coronavirus vaccines in children between 5 and 12 years, senior officials in the Health Ministry confirmed.

The move comes even as several State governments are now reimplementing COVID-19 protocols and Prime Minister Narendra Modi is scheduled to hold a meeting with Chief Ministers on April 27 on the emerging COVID-19 situation.

Biological E’s Corbevax has been approved for administration in children between the ages of 5 and 12 and Bharat Biotech’s Covaxin has been approved for restricted use in emergency situations in children aged 6-12.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.